1599$/KG
1299$/KG
Product Detailed Description
Liposomal L-5-Methyltetrahydrofolate Calcium 70% is a premium-grade dietary supplement ingredient delivering L-5-MTHF-Ca in an advanced liposomal delivery system. L-5-Methyltetrahydrofolate calcium (CAS 151533-22-1), also known as levomefolate calcium, calcium L-5-methyltetrahydrofolate, or L-5-MTHF-Ca, is the calcium salt of L-5-methyltetrahydrofolic acid. It is chemically characterized by the molecular formula C₂₀H₂₃CaN₇O₆·xH₂O (anhydrous formula weight 497.52) and is chemically designated as the calcium salt of N-[4-[[(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid. The compound occurs as a white to light yellowish, almost odorless, crystalline powder.
L-5-MTHF is the predominant naturally occurring folate in foods and the primary circulating form of folate in plasma. It is the biologically active form of folate that is directly utilized by the body without requiring enzymatic conversion by methylenetetrahydrofolate reductase (MTHFR). This distinguishes L-5-MTHF from synthetic folic acid, which must undergo multiple enzymatic reduction steps to become biologically active. L-5-MTHF is essential for DNA synthesis and repair, red blood cell formation, amino acid metabolism, and the regulation of homocysteine levels. It is particularly important for individuals with MTHFR genetic polymorphisms, who may have reduced capacity to convert folic acid to its active form.
Conventional L-5-MTHF-Ca presents significant formulation and stability challenges. The compound is sensitive to light, pH variations, oxidative stress, thermal degradation, and fermentation conditions, which can compromise its stability during storage and digestive transit. Additionally, L-5-MTHF is susceptible to degradation in the gastrointestinal environment.
Liposomal encapsulation provides four critical advantages:
1. Dramatically Enhanced Stability and Retention — Multilayer liposome-loaded 5-MTHF exhibited better physical stability and >80% 5-MTHF retention under various conditions, including salt and pH variations, as well as oxidative, thermal, fermentation, and UV stress. The phospholipid bilayer shields L-5-MTHF from degradation during storage and gastrointestinal transit, preserving its intact molecular structure until reaching optimal absorption sites.
2. Enhanced Delivery to the Small Intestine — The liposomal delivery system enhances the delivery of 5-MTHF to the small intestine, where folate absorption occurs. In vitro digestion studies demonstrated that liposomal encapsulation protects 5-MTHF during gastric transit and facilitates its release in the small intestine.
3. Superior Bioavailability vs. Folic Acid — Studies consistently demonstrate that levomefolate calcium is at least as, and in some cases more, bioavailable than folic acid. Because L-5-MTHF is already in its active form, it bypasses the MTHFR-dependent conversion step, providing direct bioavailability for cellular metabolism.
4. Water-Dispersible and Clean-Label Compatible — The liposomal powder disperses in water to re-form a liposomal suspension, making it suitable for functional beverages and liquid formulations. The phospholipid carrier is plant-derived and non-GMO, supporting clean-label positioning.
| Field | Details |
|---|---|
| Product Name | Liposomal L-5-Methyltetrahydrofolate Calcium 70% |
| CAS No. | 151533-22-1 |
| Active Ingredient | L-5-Methyltetrahydrofolate Calcium (L-5-MTHF-Ca) |
| Assay Method | HPLC with C18 reversed-phase column (250 mm × 4.6 mm, 5 μm); mobile phase acetonitrile-phosphate buffer (pH 3.0) (10:90, v/v); UV detection at 280–290 nm. Chiral HPLC with CHIRALPAK HSA column (4 mm × 150 mm, 5 μm) and phosphate buffer:acetonitrile (90:10, v/v) mobile phase for enantiomeric purity determination. USP reference standard available (Catalog No. 1379081 for Calcium D,L-5-Methyltetrahydrofolate). Standard curve prepared in the range of 0.2–10 μg/mL |
| Purity | ≥ 70% L-5-MTHF-Ca (liposomal loading); ≥ 95% (HPLC) assay available; ≥ 99% purity grades available |
| Appearance / Color | Off-white to light yellow crystalline powder (native form); white to off-white free-flowing powder (liposomal form) |
| Odor | Almost odorless |
| Solubility | Disperses in water to re-form a liposomal suspension; do not dissolve in alcohol or strong surfactants, which disrupt the liposomes |
| Dosage Form | Liposomal powder, water-dispersible |
| Recommended Dosage | 400 mcg–1 mg per day for general supplementation; 5 mg/day for therapeutic applications under medical supervision |
| Application | Prenatal health (neural tube defect prevention), red blood cell production, cardiovascular support (homocysteine regulation), DNA synthesis and cellular metabolism, nervous system health, MTHFR polymorphism support |
| Extract Source | Synthetic (synthesized from folic acid by catalytic hydrogenation or reduction with sodium borohydride followed by methylation and calcium salt formation) |
| Molecular Formula | C₂₀H₂₃CaN₇O₆·xH₂O |
| Molecular Weight | 497.52 (anhydrous) |
| Storage | Store in a cool, dry, dark place, protected from light and moisture. Keep container tightly sealed |
| Shelf Life | 24 months under proper storage conditions in unopened original packaging |
| Packaging | 1 kg/aluminum foil bag with two plastic bags inside; 25 kg/carton or fiber drum with aluminum foil bag inside |
| Lead Time | In stock: 3–5 business days; Bulk/custom orders: 2–3 weeks |
| Shipping Method | International Express (FedEx / DHL / UPS); air and sea freight available; worldwide shipping including remote areas |
High Purity — Standardized to ≥70% L-5-MTHF-Ca in the liposomal formulation, with ≥95% (HPLC) assay available.
Liposomal Enhancement — Multilayer liposome encapsulation achieves >80% 5-MTHF retention under salt, pH, oxidative, thermal, fermentation, and UV stress conditions, with enhanced delivery to the small intestine.
Directly Active Folate Form — L-5-MTHF is the predominant naturally circulating form of folate that requires no MTHFR-dependent enzymatic conversion, providing direct bioavailability for cellular metabolism.
Superior Bioavailability vs. Folic Acid — Studies consistently demonstrate that levomefolate calcium is at least as, and in some cases more, bioavailable than folic acid.
MTHFR Polymorphism Support — L-5-MTHF provides a directly usable form of folate for individuals with reduced MTHFR enzyme activity, bypassing the metabolic bottleneck that limits folic acid utilization.
Clinically Validated for Homocysteine Regulation — L-5-MTHF is a cofactor for methionine synthase, which converts homocysteine to methionine, supporting healthy homocysteine metabolism and cardiovascular health.
Water-Dispersible — Liposomal powder disperses in water to re-form a liposomal suspension; suitable for capsules, tablets, powder drink mixes, and functional beverages.
Batch Traceability — Complete COA, HPLC chromatogram, and identity data provided for each batch.
| Application | Recommended Usage | Notes |
|---|---|---|
| Capsules / Tablets | 400–800 mcg per serving | 1 capsule daily with meals |
| Functional Beverages | 200–400 mcg per 250 mL | Water-dispersible; suitable for RTD formats |
| Powdered Drink Mixes | 400–1,000 mcg per sachet | Best absorbed when taken with food |
| Prenatal Formulas | 400–800 mcg per serving | Clinical guidelines recommend 400–800 mcg/day for women planning pregnancy |
| Cardiovascular Formulas | 400–1,000 mcg per serving | Often combined with vitamin B6 and vitamin B12 for homocysteine support |
| MTHFR Support Formulas | 400–1,000 mcg per serving | Directly usable folate form for individuals with MTHFR polymorphisms |
The Recommended Dietary Allowance (RDA) for folate is 400 mcg DFE/day for adults. For supplemental use with L-5-MTHF-Ca, the usual adult dose is 1 capsule (providing 1 mg folate as L-5-MTHF-Ca) once daily, preferably with a meal or as directed by a physician. For suspected deficiency, 0.4–1 mg/day orally is usually sufficient. For therapeutic applications, 5 mg/day orally may be used until hemoglobin recovers and MCV normalizes. Women who are planning pregnancy or could become pregnant should take 400–800 mcg of folate per day before becoming pregnant. Liposomal formulations may allow for more efficient utilization of lower doses due to enhanced bioavailability and protection from degradation.
Important Safety Information: L-5-MTHF-Ca is generally well tolerated at recommended doses. High-dose folate supplementation may mask vitamin B12 deficiency, and individuals with known vitamin B12 deficiency should consult a healthcare professional before use. L-5-MTHF-Ca may interact with certain medications, including methotrexate, phenytoin, and sulfasalazine. Pregnant or lactating women and children should consult a healthcare professional before use.
L-5-Methyltetrahydrofolate Calcium Encyclopedia — Scientific Background
L-5-Methyltetrahydrofolate calcium (CAS 151533-22-1), also known as levomefolate calcium, calcium L-5-methyltetrahydrofolate, or L-5-MTHF-Ca, is the calcium salt of L-5-methyltetrahydrofolic acid (L-5-MTHF), which is the predominant naturally occurring folate in foods. It is chemically characterized by the molecular formula C₂₀H₂₃CaN₇O₆·xH₂O (anhydrous formula weight 497.52) and has a specified 1:1 ratio of L-5-methyltetrahydrofolate (L-5-MTHF) and Ca²⁺. The compound occurs as a white to light yellowish, almost odorless, crystalline powder.
| Property | Value |
|---|---|
| CAS No. | 151533-22-1 |
| Molecular Formula | C₂₀H₂₃CaN₇O₆·xH₂O |
| Molecular Weight | 497.52 (anhydrous) |
| IUPAC Name | Calcium (2S)-2-[[4-[[(6S)-2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate |
| Synonyms | Levomefolate calcium, Calcium L-5-methyltetrahydrofolate, L-5-MTHF-Ca, Metafolin |
| Appearance | Off-white to light yellow crystalline powder |
| Odor | Almost odorless |
| Purity (Standard) | ≥95% (HPLC); ≥99% available |
| UNII | A9R10K3F2F |
L-5-MTHF is the predominant naturally circulating form of folate in plasma and the primary biologically active form of folate in the human body. Unlike synthetic folic acid, which requires multiple enzymatic reduction steps—including conversion by methylenetetrahydrofolate reductase (MTHFR)—to become bioactive, L-5-MTHF is directly usable by all tissues without enzymatic conversion.
This direct bioavailability offers several potential advantages over folic acid:
No MTHFR Dependency — L-5-MTHF bypasses the MTHFR enzyme, which is subject to common genetic polymorphisms (including C677T and A1298C) that reduce enzyme activity in a significant portion of the population.
Direct Cellular Utilization — L-5-MTHF is the primary methyl donor for the remethylation of homocysteine to methionine, a reaction catalyzed by methionine synthase.
Superior Bioavailability — Studies consistently demonstrate that levomefolate calcium is at least as, and in some cases more, bioavailable than folic acid.
L-5-MTHF is critical for numerous physiological functions:
DNA Synthesis and Repair — L-5-MTHF is a coenzyme for thymidylate synthase and purine synthesis, essential for DNA replication and repair.
Red Blood Cell Production — L-5-MTHF participates in hemoglobin synthesis and the maturation and division of red blood cells.
Homocysteine Regulation — L-5-MTHF is a cofactor for methionine synthase, which converts homocysteine to methionine, supporting healthy homocysteine metabolism.
Neural Tube Development — L-5-MTHF is critical for fetal development, supporting neural tube formation and spine integrity.
Neurotransmitter Synthesis — L-5-MTHF participates in the synthesis of neurotransmitters including serotonin, dopamine, and norepinephrine.
Amino Acid Metabolism — L-5-MTHF is involved in the metabolism of several amino acids, including serine, glycine, and histidine.
L-5-MTHF is the primary methyl donor in the one-carbon metabolism pathway. It donates its methyl group to homocysteine in a reaction catalyzed by methionine synthase (which requires vitamin B12 as a cofactor), producing methionine and tetrahydrofolate (THF). Methionine is then converted to S-adenosylmethionine (SAMe), the universal methyl donor for numerous biological methylation reactions, including DNA methylation, neurotransmitter synthesis, and phospholipid metabolism.
L-5-MTHF is a cofactor for methionine synthase, which catalyzes the remethylation of homocysteine to methionine. This reaction is a major route for homocysteine disposal, and adequate L-5-MTHF levels help maintain healthy homocysteine concentrations, supporting cardiovascular health.
The MTHFR enzyme catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the rate-limiting step in the folate cycle. Common MTHFR polymorphisms (C677T and A1298C) reduce enzyme activity, limiting the conversion of folic acid to L-5-MTHF. Supplementation with L-5-MTHF bypasses this metabolic bottleneck, providing the directly usable active form of folate.
Despite its essential physiological functions, native L-5-MTHF-Ca presents significant formulation and stability challenges. The compound is sensitive to light, pH variations, oxidative stress, thermal degradation, and fermentation conditions, which can compromise its stability during storage and digestive transit.
These stability challenges have driven the development of advanced delivery systems, including liposomal encapsulation. Multilayer liposome-loaded 5-MTHF exhibited better physical stability and >80% 5-MTHF retention under various conditions, including salt and pH variations, as well as oxidative, thermal, fermentation, and UV stress. During in vitro digestion, the liposomal formulation enhanced the delivery of 5-MTHF to the small intestine, highlighting its application prospects as a stable, highly digestible folate supplement.
Liposomal encapsulation of L-5-MTHF-Ca provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the L-5-MTHF molecule, forming a protective shell that enhances stability, bioavailability, and cellular uptake. This delivery system:
Achieves >80% 5-MTHF retention under salt, pH, oxidative, thermal, fermentation, and UV stress conditions
Enhances delivery of 5-MTHF to the small intestine
Protects L-5-MTHF from gastric degradation and first-pass metabolism
Provides the directly active folate form without requiring MTHFR-dependent conversion
Disperses in water to re-form a liposomal suspension
L-5-MTHF is a cofactor for methionine synthase, which converts homocysteine to methionine. Clinical studies have demonstrated that L-5-MTHF supplementation supports healthy homocysteine metabolism, particularly in individuals with MTHFR polymorphisms who have reduced capacity to convert folic acid to its active form.
The MTHFR C677T polymorphism is present in approximately 10% of the population in homozygous form and 40% in heterozygous form, resulting in reduced enzyme activity and impaired conversion of folic acid to L-5-MTHF. Supplementation with L-5-MTHF provides a directly usable form of folate for these individuals, bypassing the metabolic bottleneck.
Adequate folate intake before and during early pregnancy significantly reduces the risk of neural tube defects such as spina bifida and anencephaly. Clinical guidelines recommend that women who are planning pregnancy or could become pregnant should take 400–800 mcg of folate per day before becoming pregnant.
L-5-MTHF-Ca has a well-established safety profile. The Tolerable Upper Intake Level (UL) for folic acid from supplements is 1,000 mcg/day for adults. High-dose folate supplementation may mask vitamin B12 deficiency.
Regulatory Status:
United States — L-5-MTHF-Ca is regulated as a dietary supplement ingredient and food additive. It is Generally Recognized As Safe (GRAS) for use in food and dietary supplements. It is monographed in the USP with a reference standard available (Catalog No. 1379081 for Calcium D,L-5-Methyltetrahydrofolate).
European Union — L-5-MTHF-Ca is authorized as a vitamin and mineral substance which may be used in the manufacture of food supplements. It is monographed in the European Pharmacopoeia.
Global Standards — L-5-MTHF-Ca is monographed in the USP, European Pharmacopoeia, and Food Chemicals Codex (FCC). The product is available with Halal and Kosher certifications.
Precautions: L-5-MTHF-Ca is generally well tolerated at recommended doses. High-dose folate supplementation may mask vitamin B12 deficiency. Individuals with known vitamin B12 deficiency should consult a healthcare professional before use. L-5-MTHF-Ca may interact with certain medications, including methotrexate, phenytoin, and sulfasalazine. Pregnant or lactating women and children should consult a healthcare professional before use.
Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.
This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.
1599$/KG
1299$/KG
RELATED
RELATED
RELATED
RELATED
This website uses cookies to ensure you get the best experience on our website.
Comment
(0)